[
    "{\"step_by_step_thinking\": \"The patient has osteoporosis, as indicated by a T-score of -2.6 SD. The drug that both prevents further bone resorption and reduces the risk of developing breast cancer is likely a selective estrogen receptor modulator (SERM), such as raloxifene. SERMs are known to increase the risk of deep vein thrombosis.\", \"answer_choice\": \"D\"}"
]